<DOC>
	<DOCNO>NCT01539473</DOCNO>
	<brief_summary>Phase 1 study determine effect oral TR-701 FA SBP response administer tyramine</brief_summary>
	<brief_title>A Phase 1 TR-701 FA Study Blood Pressure Response Post Tyramine Challenge</brief_title>
	<detailed_description>This Phase 1 , randomize , double-blind , placebo-controlled , 2-way crossover study determine effect 200 mg oral TR-701 FA SBP response administer tyramine healthy adult male female volunteer .</detailed_description>
	<mesh_term>Torezolid phosphate</mesh_term>
	<mesh_term>Tyramine</mesh_term>
	<criteria>Male female subject 18 45 year age , inclusive Body mass index 19 kg/m2 31 kg/m2 , inclusive Healthy subject clinically significant abnormality identify detailed medical history , Systolic blood pressure &gt; 130 mmHg &lt; 90 mmHg measure 10 minute supine position Screening admission study center Heart rate &gt; 90 bpm &lt; 45 bpm measure 10 minute supine position Electrocardiogram ( ECG ) find QTc interval &gt; 500 msec , clinically significant ECG abnormality Screening Visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>